This Rare Gene Drastically Raises Lung Cancer Risk in People Who Never Smoked
The brief
- Velocity & Diffusion: Coverage escalated across 17 distinct news outlets with 18 published articles, achieving a live velocity of 19.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"This Rare Gene Drastically Raises Lung Cancer Risk in People Who Never Smoked" developed substantial multi-source reporting across the Health sector, tracked across 11 distinct newsrooms by Newsylist.
Key reporting was led by Yahoo! Finance Canada, The Boston Globe, yahoo.com and NYT > Health. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 5d ago.
Coverage (18)
-
-
-
-
-
-
-
-
☕️ Show me the money Healthcare Brew · 5d ago
-
-
-
-
-
-
-
-
-
-
This Rare Gene Drastically Raises Lung Cancer Risk in People Who Never Smoked The New York Times · 5d ago broke it first
Quick answers
What drove coverage for This Rare Gene Drastically Raises Lung Cancer Risk in People Who Never Smok?
Coverage spiked when 11 independent newsrooms published 11 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
People, places & organizations
From around our network
- Cork Breast Cancer Trial to Pioneer Personalized Treatment Using Blood Tests world-today-news.com
- Experimental Drug CS18 Overcomes Cancer Drug Resistance newsdirectory3.com